KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $144,000 | -19.1% | 42,350 | -10.6% | 0.02% | -28.6% |
| Q2 2018 | $178,000 | -10.1% | 47,350 | -2.1% | 0.03% | -9.7% |
| Q1 2018 | $198,000 | -15.4% | 48,350 | -4.0% | 0.03% | -13.9% |
| Q4 2017 | $234,000 | -63.7% | 50,350 | -44.5% | 0.04% | -28.0% |
| Q3 2017 | $644,000 | +96.3% | 90,700 | +100.0% | 0.05% | -7.4% |
| Q2 2017 | $328,000 | +17.6% | 45,350 | 0.0% | 0.05% | +14.9% |
| Q1 2017 | $279,000 | +4.9% | 45,350 | 0.0% | 0.05% | +2.2% |
| Q4 2016 | $266,000 | +1.5% | 45,350 | -8.1% | 0.05% | -2.1% |
| Q3 2016 | $262,000 | -14.7% | 49,350 | +6.5% | 0.05% | -17.5% |
| Q2 2016 | $307,000 | +42.1% | 46,350 | 0.0% | 0.06% | +83.9% |
| Q1 2016 | $216,000 | -7.7% | 46,350 | 0.0% | 0.03% | -29.5% |
| Q4 2015 | $234,000 | -55.0% | 46,350 | -11.0% | 0.04% | -49.4% |
| Q2 2015 | $520,000 | -21.6% | 52,100 | 0.0% | 0.09% | -24.3% |
| Q1 2015 | $663,000 | -5.3% | 52,100 | +5.3% | 0.12% | +30.7% |
| Q4 2014 | $700,000 | +4.9% | 49,500 | +2.1% | 0.09% | -4.3% |
| Q3 2014 | $667,000 | -11.9% | 48,500 | -1.5% | 0.09% | -36.6% |
| Q2 2014 | $757,000 | -15.8% | 49,250 | -6.6% | 0.14% | -22.9% |
| Q1 2014 | $899,000 | +35.4% | 52,750 | +2.9% | 0.19% | +437.1% |
| Q4 2013 | $664,000 | +28.4% | 51,250 | 0.0% | 0.04% | -70.6% |
| Q3 2013 | $517,000 | +35.0% | 51,250 | 0.0% | 0.12% | +7.2% |
| Q2 2013 | $383,000 | – | 51,250 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |